• Home

  • Documents

  • Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of...
9

Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 2: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 3: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 4: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 5: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 6: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 7: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 8: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant
Page 9: Amgen Inc. - ComplaintDefendant AMGEN INC. is a Delaware corporation with its principal place of business at I Amgen Center Drive in Thousand Oaks, California 91320. At all relevant

Q1 2020 Earnings Call - Amgen Inc

Q1 2020 Earnings Call - Amgen Inc

Documents
eligibility2019comments a amgen 2019mar08...Amgen Inc. provides the following comments in response to the notices identified above and thanks the United States Patent and Trademark

eligibility2019comments a amgen 2019mar08...Amgen Inc. provides the following comments in response to the notices identified above and thanks the United States Patent and Trademark

Documents
Amgen Inc PARSABIV- etelcalcetide injection, solution

Amgen Inc PARSABIV- etelcalcetide injection, solution

Documents
U.S. EX REL. WESTMORELAND v. AMGEN, INC. 39thomasdurrell.com/wp-content/uploads/2016/02/Amgen-09-15-11-1.pdf · U.S. EX REL. WESTMORELAND v. AMGEN, INC.39 ... States Sentencing Guidelines

U.S. EX REL. WESTMORELAND v. AMGEN, INC. 39thomasdurrell.com/wp-content/uploads/2016/02/Amgen-09-15-11-1.pdf · U.S. EX REL. WESTMORELAND v. AMGEN, INC.39 ... States Sentencing Guidelines

Documents
Amgen Inc. 2013 Annual Report

Amgen Inc. 2013 Annual Report

Investor Relations
Amgen Inc. v. Hospira, Inc. · Amgen Inc. v. Sandoz Inc., 794 F.3d 1347, 1356 (Fed. Cir. 2015). If Hospira is permitted to withhold information expressly called for by § 262(l)(2)(A)

Amgen Inc. v. Hospira, Inc. · Amgen Inc. v. Sandoz Inc., 794 F.3d 1347, 1356 (Fed. Cir. 2015). If Hospira is permitted to withhold information expressly called for by § 262(l)(2)(A)

Documents
In the Supreme Court of the United States · Amgen Inc., Amgen Manufacturing Limited, and Amgen USA, Inc., Petitioners, v. Sanofi, Aventisub LLC, Regeneron Pharmaceuticals Inc., and

In the Supreme Court of the United States · Amgen Inc., Amgen Manufacturing Limited, and Amgen USA, Inc., Petitioners, v. Sanofi, Aventisub LLC, Regeneron Pharmaceuticals Inc., and

Documents
Omiecinski*vbs.psu.edu/research/labs/omiecinski/selected...‡Current address: Amgen Pharmacokinetics and Drug Metabolism, 1 Amgen Center Dr, Mailstop 30E-2-C, Thousand Oaks, CA 91320

Omiecinski*vbs.psu.edu/research/labs/omiecinski/selected...‡Current address: Amgen Pharmacokinetics and Drug Metabolism, 1 Amgen Center Dr, Mailstop 30E-2-C, Thousand Oaks, CA 91320

Documents
AMGEN - Patterson Belknap Webb & Tyler€¦ · 1 See §II of “Comments of Amgen Inc. on GPhA and Novartis’s citizen petitions requesting identical non‐proprietary names for

AMGEN - Patterson Belknap Webb & Tyler€¦ · 1 See §II of “Comments of Amgen Inc. on GPhA and Novartis’s citizen petitions requesting identical non‐proprietary names for

Documents
CONTRIBUTORS - Springer978-0-306-48523-7/1.pdfCONTRIBUTORS *Presenting authors ... Agoram, Balaji Amgen, Inc. 1 Amgen Center Drive ... La Jolla, CA 92093-0979 ecapparelli@ucsd.edu

CONTRIBUTORS - Springer978-0-306-48523-7/1.pdfCONTRIBUTORS *Presenting authors ... Agoram, Balaji Amgen, Inc. 1 Amgen Center Drive ... La Jolla, CA 92093-0979 [email protected]

Documents
Amgen 401(k) - 2017 SPD FINALamgenbenefits.com/Documents/Amgen 401(k) - 2017 SPD FINAL.pdf · Amgen - refers to Amgen Inc. Amgen Common Stock - refers to the common stock of Amgen

Amgen 401(k) - 2017 SPD FINALamgenbenefits.com/Documents/Amgen 401(k) - 2017 SPD FINAL.pdf · Amgen - refers to Amgen Inc. Amgen Common Stock - refers to the common stock of Amgen

Documents
This study was funded by Amgen Inc

This study was funded by Amgen Inc

Documents
February 10, 2017 Andrea A. Robinson - SEC.gov | HOME · February 10, 2017 . Andrea A. Robinson . Amgen Inc. robinson@amgen.com . Re: Amgen Inc. Incoming letter dated January 13,

February 10, 2017 Andrea A. Robinson - SEC.gov | HOME · February 10, 2017 . Andrea A. Robinson . Amgen Inc. [email protected] . Re: Amgen Inc. Incoming letter dated January 13,

Documents
F345A 20180601 91320 10000006504

F345A 20180601 91320 10000006504

Documents
B296563 Amgen Inc. v. The California Correctional Health ... · 13/04/2020  · AMGEN INC., Plaintiff and Respondent, v. THE CALIFORNIA CORRECTIONAL HEALTH CARE SERVICES, Defendant

B296563 Amgen Inc. v. The California Correctional Health ... · 13/04/2020  · AMGEN INC., Plaintiff and Respondent, v. THE CALIFORNIA CORRECTIONAL HEALTH CARE SERVICES, Defendant

Documents
Amgen Inc.; Rule 14a-8 no-action letter - SEC...Aigen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Re: Amgen Inc. Incoming letter dated Janua 5, 2009 Dear Ms. Robinson:

Amgen Inc.; Rule 14a-8 no-action letter - SEC...Aigen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 Re: Amgen Inc. Incoming letter dated Janua 5, 2009 Dear Ms. Robinson:

Documents
2016 ANNUAL REPORT - PhRMA FoundationAMAG Pharmaceuticals, Inc. Amgen Inc. Astellas Pharma US, Inc. Avanir Pharmaceuticals, Inc. Biogen BioMarin Pharmaceutical, Inc. Bristol-Myers

2016 ANNUAL REPORT - PhRMA FoundationAMAG Pharmaceuticals, Inc. Amgen Inc. Astellas Pharma US, Inc. Avanir Pharmaceuticals, Inc. Biogen BioMarin Pharmaceutical, Inc. Bristol-Myers

Documents
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ... · Plaintiffs Amgen Inc. and Amgen Manufacturing Limited (collectively, “Amgen”) respectfully object to the Magistrate

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ... · Plaintiffs Amgen Inc. and Amgen Manufacturing Limited (collectively, “Amgen”) respectfully object to the Magistrate

Documents
Amgen Inc. 2000 Annual Report€¦ · Amgen 2000 Annual Report dramatically improving people’s lives vitality freedom ... the strategy, and the resources necessary to make our future

Amgen Inc. 2000 Annual Report€¦ · Amgen 2000 Annual Report dramatically improving people’s lives vitality freedom ... the strategy, and the resources necessary to make our future

Documents
Healthcare Amgen Inc. (NASDAQ: AMGN) Recommendation: …Amgen Inc. is the second largest company in the biotechnology industry, which has a market cap of $124.232 billion. The core

Healthcare Amgen Inc. (NASDAQ: AMGN) Recommendation: …Amgen Inc. is the second largest company in the biotechnology industry, which has a market cap of $124.232 billion. The core

Documents
Amgen Inc BLINCYTO- blinatumomab

Amgen Inc BLINCYTO- blinatumomab

Documents
Amgen Inc MVASI- bevacizumab-awwb injection, solution

Amgen Inc MVASI- bevacizumab-awwb injection, solution

Documents
Amgen Inc. v. Connecticut Retirement Plans and Trust Funds

Amgen Inc. v. Connecticut Retirement Plans and Trust Funds

Documents
N HE Supreme Court of the United States - SCOTUSblog · Nos. 15-1039 & 15-1195 IN THE Supreme Court of the United States _____ SANDOZ INC., Petitioner, v. AMGEN INC. AND AMGEN MANUFACTURING

N HE Supreme Court of the United States - SCOTUSblog · Nos. 15-1039 & 15-1195 IN THE Supreme Court of the United States _____ SANDOZ INC., Petitioner, v. AMGEN INC. AND AMGEN MANUFACTURING

Documents
BACKGROUND INFORMATION FOR THE ONCOLOGIC … July 2017 Oncologic Drugs Advisory Committee Meeting Briefing Document ABP 215, ... Amgen Inc 1 Amgen Center Drive Thousand Oaks‚ CA

BACKGROUND INFORMATION FOR THE ONCOLOGIC … July 2017 Oncologic Drugs Advisory Committee Meeting Briefing Document ABP 215, ... Amgen Inc 1 Amgen Center Drive Thousand Oaks‚ CA

Documents
FOR THE SOUTHERN DISTRICT OF FLORIDA AMGEN INC. and AMGEN … · 1. Amgen Inc. is a corporation existing under the laws of the State of Delaware, with its principal place of business

FOR THE SOUTHERN DISTRICT OF FLORIDA AMGEN INC. and AMGEN … · 1. Amgen Inc. is a corporation existing under the laws of the State of Delaware, with its principal place of business

Documents
AMGEN INC. et al., Petitioners Supreme Court of the …blogs.reuters.com/alison-frankel/files/2013/09/Amgen-Inc-v... · ... 133 S.Ct. 1184 (2013) ... Federal Civil Procedure Stockholders,

AMGEN INC. et al., Petitioners Supreme Court of the …blogs.reuters.com/alison-frankel/files/2013/09/Amgen-Inc-v... · ... 133 S.Ct. 1184 (2013) ... Federal Civil Procedure Stockholders,

Documents
Q1 ’21 EARNINGS ALL - Amgen Inc

Q1 ’21 EARNINGS ALL - Amgen Inc

Documents
2020 Annual Letter 10-K - Investors | Amgen Inc

2020 Annual Letter 10-K - Investors | Amgen Inc

Documents
AMGEN INC, Decided July 30, 1998. · 6/23/1998  · AMGEN INC, Defendant. No. CIV.A. 96-587 MMS Argued June 23, 1998. Decided July 30, 1998. Patentee and its licensee brought patent

AMGEN INC, Decided July 30, 1998. · 6/23/1998  · AMGEN INC, Defendant. No. CIV.A. 96-587 MMS Argued June 23, 1998. Decided July 30, 1998. Patentee and its licensee brought patent

Documents